Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Creative Planning

Creative Planning grew its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 13.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,104 shares of the company’s stock after acquiring an additional 2,671 shares during the period. Creative Planning’s holdings in Doximity were worth $963,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. GAMMA Investing LLC grew its stake in Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the last quarter. Van ECK Associates Corp grew its position in shares of Doximity by 19.7% during the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after acquiring an additional 427 shares during the last quarter. Cornercap Investment Counsel Inc. grew its position in shares of Doximity by 3.2% during the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock worth $479,000 after acquiring an additional 537 shares during the last quarter. Arizona State Retirement System grew its position in shares of Doximity by 2.4% during the second quarter. Arizona State Retirement System now owns 30,779 shares of the company’s stock worth $861,000 after acquiring an additional 725 shares during the last quarter. Finally, First Horizon Advisors Inc. grew its position in shares of Doximity by 80.0% during the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock worth $48,000 after acquiring an additional 760 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Stock Up 1.5 %

Doximity stock opened at $42.35 on Friday. The stock has a 50-day simple moving average of $40.66 and a 200 day simple moving average of $32.33. Doximity, Inc. has a 12-month low of $20.28 and a 12-month high of $44.88. The stock has a market capitalization of $7.86 billion, a price-to-earnings ratio of 52.94, a P/E/G ratio of 5.05 and a beta of 1.29.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. The firm had revenue of $126.68 million during the quarter, compared to analyst estimates of $119.88 million. Doximity had a return on equity of 19.26% and a net margin of 32.53%. As a group, sell-side analysts anticipate that Doximity, Inc. will post 0.8 EPS for the current year.

Insider Buying and Selling

In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of Doximity stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the completion of the sale, the director now directly owns 11,258 shares in the company, valued at $287,529.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the transaction, the chief financial officer now directly owns 309,627 shares in the company, valued at approximately $10,836,945. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $25.54, for a total value of $25,820.94. Following the completion of the transaction, the director now owns 11,258 shares of the company’s stock, valued at $287,529.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 37.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DOCS. Barclays upgraded shares of Doximity from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $35.00 to $52.00 in a research report on Tuesday, October 15th. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. JPMorgan Chase & Co. raised their price objective on shares of Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research report on Monday, August 19th. Bank of America upped their price objective on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a research note on Monday, October 7th. Finally, Evercore ISI upped their price objective on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Doximity presently has a consensus rating of “Hold” and a consensus target price of $36.42.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.